Braveheart Bio
BRVE
20.39
+1.12
+5.81%
Braveheart Bio
US · BRVE
#2845 by market cap
Listed 2026
20.39
+1.12
+5.81%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 5 analysts
Buy
Avg price target 45.50 +123.1%
Price target rangecurrent 20.39
Low40.00
Avg45.50
High49.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (13)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-11 | Goldman Sachs | -- | Buy | 49.00 |
| 2026-11-09 | Stifel | -- | Buy | 45.00 |
| 2026-11-07 | Cantor Fitzgerald | -- | Buy | 40.00 |
| 2026-10-19 | Cantor Fitzgerald | -- | Buy | 40.00 |
| 2026-10-01 | Stifel | -- | Buy | 45.00 |
| 2026-09-09 | Stifel | -- | Buy | 45.00 |
| 2026-09-08 | Goldman Sachs | -- | Buy | 48.00 |
| 2026-09-06 | Stifel | -- | Buy | 45.00 |
| 2026-08-31 | TD Cowen | -- | Buy | -- |
| 2026-08-31 | Cantor Fitzgerald | -- | Buy | 40.00 |
| 2026-08-31 | Jefferies | -- | Buy | 48.00 |
| 2026-08-31 | Stifel | -- | Buy | 45.00 |
| 2026-08-31 | Goldman Sachs | -- | Buy | 48.00 |
Price target trend monthly average, last 3 years
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Braveheart Bio discussion 0 comments